Search results

Showing 1 - 10 of 10 results

Sort results by: date | relevance

Search filters:

By Article Type

  • Analysis Remove publication filter

By Channel

  • Public Relations Remove filter
    • Healthcare PR Remove filter

Click remove filters icon to remove filters

Clear this search

Add Search Filters:

By Date

By Publication

Do you need a degree to work in PR?

01 Mar 2012 | by Joe Lepper

The majority of PR recruits now have a degree, but is it necessary?

MEDIA ANALYSIS: BBC health news sets the agenda

08 May 2008 | by Gemma O'Reilly

The BBC news website’s recently redesigned health page is becoming the first port of call for PROs in the sector. Gemma O’Reilly looks at how to secure coverage.

NEWS ANALYSIS: Are blogs damaging pharma firms?

07 Nov 2007 | by Gemma O'Reilly

Patients are increasingly turning to the internet in order to select their own treatments. Gemma O'Reilly considers the implications for pharma PROs whose ability to influence blog chat is limited by regulations.

NEWS ANALYSIS: Hospital survival hangs on comms

18 Jul 2007 | by Kate Magee

As a new health minister moots a huge restructure of the NHS in London, unions and pressure groups are looking at how they can defend hospital services. Kate Magee analyses some tactics employed in the past.

NEWS ANALYSIS: Ketchum comes out of the shade

20 Jun 2007 | by Robert Gray

US-owned Ketchum is seeing steady growth and is perceived as an excellent place to work, but is there a sense that it could do better? Robert Gray reports.

News Analysis: B-M bullish after pharma faux pas

08 Nov 2006 | by Alex Black

Burson-Marsteller UK has travelled a 'rocky road' of late with misconduct in its health team and the exit of senior staff. But Alex Black finds the group optimistic.

Analysis: Shining a light on clinical research

04 May 2006 | by David Noble

Contract research organisations are increasingly coming under media scrutiny and need to step up their comms efforts, warns a healthcare PR expert

Only facts can kill healthcare fiction

01 Dec 2005 | by Roy Sutherwood

The DoH infuriated the tabloids by excluding them from a briefing on the flu-vaccine shortage. An ex-DoH head of news assesses how to deal with scare stories

Can Merck bounce back from Vioxx?

24 Nov 2005 | by David Quainton

As the first federal case over withdrawn painkiller Vioxx goes to trial in the US, David Quainton looks at Merck’s fall from grace and the implications for the pharma trade

Analysis: The drug buoyed by patient power

13 Oct 2005 | by Ian Hall

The clamour for a Roche breast-cancer drug reached fever pitch last week. Ian Hall asks what PROs can learn from Herceptin’s stint in the media spotlight

Additional Information

Latest jobs Jobs web feed


Part of the Brand Republic Group